$FEMY
FEMASYS INC

2023 Q1 Form 10-K Financial Statement

#000114036123014668 Filed on March 30, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $294.0K $234.2K $1.206M
YoY Change -8.53% -7.9% 2.25%
Cost Of Revenue $105.1K $85.46K $441.9K
YoY Change -14.31% 32.89% 19.32%
Gross Profit $188.9K $148.8K $764.3K
YoY Change -4.96% -21.7% -5.56%
Gross Profit Margin 64.24% 63.52% 63.36%
Selling, General & Admin $1.560M $1.743M $5.990M
YoY Change 2.89% 28.9% 33.97%
% of Gross Profit 826.01% 1171.39% 783.69%
Research & Development $1.537M $1.272M $5.814M
YoY Change 8.19% 20.66% 42.34%
% of Gross Profit 814.05% 854.69% 760.68%
Depreciation & Amortization $131.7K $134.7K $539.4K
YoY Change -8.7% -5.01% -2.12%
% of Gross Profit 69.71% 90.57% 70.58%
Operating Expenses $3.231M $3.149M $12.36M
YoY Change 4.84% 23.61% 35.19%
Operating Profit -$3.042M -$3.000M -$11.60M
YoY Change 5.51% 27.26% 39.15%
Interest Expense $1.672K $114.8K $13.46K
YoY Change -38.84% -4098.26% -29.97%
% of Operating Profit
Other Income/Expense, Net $95.42K -$2.280K $212.4K
YoY Change -34177.5% 812.0% -73.55%
Pretax Income -$2.946M -$2.888M -$11.39M
YoY Change 2.19% 22.32% 51.16%
Income Tax $6.300K $6.300K
% Of Pretax Income
Net Earnings -$2.946M -$2.894M -$11.39M
YoY Change 2.19% 22.38% 51.16%
Net Earnings / Revenue -1002.18% -1235.57% -944.62%
Basic Earnings Per Share -$0.25 -$0.96
Diluted Earnings Per Share -$0.25 -$0.24 -$0.96
COMMON SHARES
Basic Shares Outstanding 11.87M 11.81M 11.82M
Diluted Shares Outstanding 11.87M 11.82M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.16M $12.96M $12.96M
YoY Change -53.32% -47.7% -47.7%
Cash & Equivalents $10.16M $12.96M
Short-Term Investments
Other Short-Term Assets $542.1K $655.4K $655.4K
YoY Change -4.45% 17.9% 17.9%
Inventory $500.7K $436.7K $436.7K
Prepaid Expenses
Receivables $124.0K $77.47K $77.47K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $11.33M $14.13M $14.13M
YoY Change -50.16% -44.87% -44.87%
LONG-TERM ASSETS
Property, Plant & Equipment $1.378M $1.483M $1.803M
YoY Change -36.27% -7.25% -20.41%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $920.8K $958.2K $958.2K
YoY Change 47.23% 46.19% 46.19%
Total Long-Term Assets $2.540M $2.764M $2.764M
YoY Change -9.46% -6.15% -6.15%
TOTAL ASSETS
Total Short-Term Assets $11.33M $14.13M $14.13M
Total Long-Term Assets $2.540M $2.764M $2.764M
Total Assets $13.87M $16.90M $16.90M
YoY Change -45.69% -40.88% -40.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $526.8K $510.8K $510.8K
YoY Change -3.94% 14.64% 14.64%
Accrued Expenses $535.4K $456.7K $456.7K
YoY Change -5.27% -24.36% -24.36%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $305.1K $515.1K $515.1K
YoY Change -31.64% -12.36% -12.36%
Total Short-Term Liabilities $1.413M $1.528M $1.528M
YoY Change -13.45% -9.71% -9.71%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $28.58K $28.58K
YoY Change -100.0% -92.9% -92.9%
Other Long-Term Liabilities $98.82K $96.66K $96.66K
YoY Change -3.59% -35.47%
Total Long-Term Liabilities $98.82K $125.2K $125.2K
YoY Change -75.75% -77.32% -77.32%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.413M $1.528M $1.528M
Total Long-Term Liabilities $98.82K $125.2K $125.2K
Total Liabilities $1.511M $1.653M $1.653M
YoY Change -25.9% -26.34% -26.34%
SHAREHOLDERS EQUITY
Retained Earnings -$97.08M -$94.13M
YoY Change 13.77%
Common Stock $11.99K $11.99K
YoY Change 0.55%
Preferred Stock
YoY Change
Treasury Stock (at cost) $60.00K $60.00K
YoY Change 0.0%
Treasury Stock Shares $117.2K $117.2K
Shareholders Equity $12.36M $15.24M $15.24M
YoY Change
Total Liabilities & Shareholders Equity $13.87M $16.90M $16.90M
YoY Change -45.69% -40.88% -40.88%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$2.946M -$2.894M -$11.39M
YoY Change 2.19% 22.38% 51.16%
Depreciation, Depletion And Amortization $131.7K $134.7K $539.4K
YoY Change -8.7% -5.01% -2.12%
Cash From Operating Activities -$2.648M -$2.868M -$10.73M
YoY Change -3.86% 27.58% 35.32%
INVESTING ACTIVITIES
Capital Expenditures $8.901K $93.88K $407.5K
YoY Change -107.39% -179.14% 32.79%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$8.901K -$93.88K -$407.5K
YoY Change -92.61% -20.86% 32.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $79.46K
YoY Change -99.75%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -144.1K -81.95K -681.6K
YoY Change 2.16% -37.32% -102.3%
NET CHANGE
Cash From Operating Activities -2.648M -2.868M -10.73M
Cash From Investing Activities -8.901K -93.88K -407.5K
Cash From Financing Activities -144.1K -81.95K -681.6K
Net Change In Cash -2.801M -3.044M -11.82M
YoY Change -7.12% 21.88% -155.08%
FREE CASH FLOW
Cash From Operating Activities -$2.648M -$2.868M -$10.73M
Capital Expenditures $8.901K $93.88K $407.5K
Free Cash Flow -$2.657M -$2.962M -$11.14M
YoY Change 0.87% 39.1% 35.23%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
379713
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4700370
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4321129
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3217319
CY2021Q4 us-gaap Assets Current
AssetsCurrent
25631410
CY2022Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
1195637
CY2021Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
1155332
CY2022Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
99344
CY2021Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
99344
CY2022Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
419303
CY2021Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
424947
CY2022Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
2572243
CY2021Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
2261793
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1483051
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1599012
CY2022Q4 femy Operating Lease And Finance Lease Right Of Use Asset
OperatingLeaseAndFinanceLeaseRightOfUseAsset
319557
CY2021Q4 femy Operating Lease And Finance Lease Right Of Use Asset
OperatingLeaseAndFinanceLeaseRightOfUseAsset
665747
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3294
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
25093
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
958177
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
655418
CY2022Q4 us-gaap Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment
AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
1281028
CY2021Q4 us-gaap Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment
AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
1346258
CY2022Q4 us-gaap Assets
Assets
16895570
CY2021Q4 us-gaap Liabilities
Liabilities
2244298
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11986927
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11869704
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11921388
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
60000
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
60000
CY2022Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
567972
CY2021Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
702492
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
108857065
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
108418304
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-94134505
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-82740335
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
15242519
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
26332382
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16895570
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
28576680
CY2022 us-gaap Operating Expenses
OperatingExpenses
12364544
CY2021 us-gaap Operating Expenses
OperatingExpenses
9146109
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-11600264
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-8336804
CY2022 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
228164
CY2021 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
3768
CY2022 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0
CY2021 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
821515
CY2022 us-gaap Interest Expense
InterestExpense
13464
CY2021 us-gaap Interest Expense
InterestExpense
19226
CY2022 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
2306
CY2021 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
3098
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
212394
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
802959
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11387870
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7533845
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6300
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-11394170
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-7537845
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11394170
CY2022 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-11394170
CY2021 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-7537845
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7537845
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.96
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.96
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.12
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11815019
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11815019
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6712028
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-51815728
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
16151
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
15242519
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-11394170
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-7537845
CY2022 us-gaap Depreciation
Depreciation
539434
CY2021 us-gaap Depreciation
Depreciation
551092
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
21799
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
39976
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
327907
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
373219
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-383616
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-413212
CY2022 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-62911
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
79463
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
31740046
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
505205
CY2021 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
442086
CY2022 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
23058
CY2021 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
20861
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-681645
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
29698456
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-11821093
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
21460803
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24783029
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3322226
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12961936
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24783029
CY2022 us-gaap Interest Paid Net
InterestPaidNet
13464
CY2021 us-gaap Interest Paid Net
InterestPaidNet
15865
CY2021 femy Prepaid Insurance Financed With Promissory Note
PrepaidInsuranceFinancedWithPromissoryNote
181123
CY2022 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12961936
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-11394170
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001339005
CY2022Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://femasys.com/20221231#OperatingLeaseAndFinanceLeaseRightOfUseAsset
CY2021Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://femasys.com/20221231#OperatingLeaseAndFinanceLeaseRightOfUseAsset
CY2021Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://femasys.com/20221231#OperatingAndFinanceLeaseLiabilityCurrent
CY2022Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://femasys.com/20221231#OperatingAndFinanceLeaseLiabilityCurrent
CY2022Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://femasys.com/20221231#OperatingAndFinanceLeaseLiabilityNoncurrent
CY2021Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://femasys.com/20221231#OperatingAndFinanceLeaseLiabilityNoncurrent
CY2022Q4 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://femasys.com/20221231#OperatingLeaseAndFinanceLeaseRightOfUseAsset
CY2021Q4 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://femasys.com/20221231#OperatingLeaseAndFinanceLeaseRightOfUseAsset
CY2021Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://femasys.com/20221231#OperatingAndFinanceLeaseLiabilityCurrent
CY2022Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://femasys.com/20221231#OperatingAndFinanceLeaseLiabilityCurrent
CY2021Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://femasys.com/20221231#OperatingAndFinanceLeaseLiabilityNoncurrent
CY2022Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://femasys.com/20221231#OperatingAndFinanceLeaseLiabilityNoncurrent
CY2021Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.11
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Auditor Firm
AuditorFirmId
185
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2024-01-31
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-40492
CY2022 dei Entity Registrant Name
EntityRegistrantName
Femasys Inc.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
11-3713499
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
3950 Johns Creek Court
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Suwanee
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30024
CY2022 dei City Area Code
CityAreaCode
770
CY2022 dei Local Phone Number
LocalPhoneNumber
500-3910
CY2022 dei Security12b Title
Security12bTitle
Common stock, par value $0.001
CY2022 dei Trading Symbol
TradingSymbol
FEMY
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
23117474
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11872573
CY2022 dei Auditor Name
AuditorName
KPMG LLP
CY2022 dei Auditor Location
AuditorLocation
Atlanta, Georgia
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12961936
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24783029
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
77470
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
84258
CY2022Q4 us-gaap Inventory Net
InventoryNet
436723
CY2021Q4 us-gaap Inventory Net
InventoryNet
208270
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
655362
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
555853
CY2022Q4 us-gaap Assets Current
AssetsCurrent
14131491
CY2022Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
413843
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2722117
CY2021Q4 us-gaap Assets
Assets
28576680
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
510758
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
445522
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
456714
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
603787
CY2022Q4 femy Clinical Holdback Current
ClinicalHoldbackCurrent
45206
CY2021Q4 femy Clinical Holdback Current
ClinicalHoldbackCurrent
18947
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
141298
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
181123
CY2022Q4 femy Operating And Finance Lease Liability Current
OperatingAndFinanceLeaseLiabilityCurrent
373833
CY2021Q4 femy Operating And Finance Lease Liability Current
OperatingAndFinanceLeaseLiabilityCurrent
406674
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
0
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
36037
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1527809
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1692090
CY2022Q4 femy Clinical Holdback Noncurrent
ClinicalHoldbackNoncurrent
96658
CY2021Q4 femy Clinical Holdback Noncurrent
ClinicalHoldbackNoncurrent
149791
CY2022Q4 femy Operating And Finance Lease Liability Noncurrent
OperatingAndFinanceLeaseLiabilityNoncurrent
28584
CY2021Q4 femy Operating And Finance Lease Liability Noncurrent
OperatingAndFinanceLeaseLiabilityNoncurrent
402417
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
125242
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
552208
CY2022Q4 us-gaap Liabilities
Liabilities
1653051
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11804165
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
11987
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
11921
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
117223
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
117223
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1206218
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1179689
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
441938
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
370384
CY2022 us-gaap Gross Profit
GrossProfit
764280
CY2021 us-gaap Gross Profit
GrossProfit
809305
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5813755
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4084304
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
558852
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
208735
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5430704
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4262002
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
561233
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
591068
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.12
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6712028
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
126546
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
30022357
CY2021 femy Automatic Conversion Of Preferred Stock In Connection With Ipo
AutomaticConversionOfPreferredStockInConnectionWithIPO
55343686
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
193366
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-7537845
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
26332382
CY2022 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3729
CY2022 femy Stock Issuance Costs
StockIssuanceCosts
95
CY2022 femy Stock Issued During Period Value At The Market Offering Net Of Issuance Costs
StockIssuedDuringPeriodValueAtTheMarketOfferingNetOfIssuanceCosts
59488
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
224939
CY2022 femy Expiration Of Warrant
ExpirationOfWarrant
0
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-11394170
CY2022 us-gaap Inventory Lifo Reserve Period Charge
InventoryLIFOReservePeriodCharge
4100
CY2021 us-gaap Inventory Lifo Reserve Period Charge
InventoryLIFOReservePeriodCharge
540
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
224939
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
193366
CY2022 us-gaap Other Noncash Income
OtherNoncashIncome
0
CY2021 us-gaap Other Noncash Income
OtherNoncashIncome
821515
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-2285
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-3098
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6788
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-41532
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
232553
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
77432
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-295862
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-475993
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
65236
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-228811
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-147073
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-504799
CY2021 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-25987
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10731973
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7930785
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
407475
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
306868
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-407475
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-306868
CY2022 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
232845
CY2021 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
1578643
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5050
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
800
CY2022 femy Conversion Of Convertible Preferred Stock To Common Stock
ConversionOfConvertiblePreferredStockToCommonStock
0
CY2021 femy Conversion Of Convertible Preferred Stock To Common Stock
ConversionOfConvertiblePreferredStockToCommonStock
55360897
CY2022 femy Commission Costs Relating To Certain Proceeds From Issuance Of Common Stock
CommissionCostsRelatingToCertainProceedsFromIssuanceOfCommonStock
1843
CY2021 femy Commission Costs Relating To Certain Proceeds From Issuance Of Common Stock
CommissionCostsRelatingToCertainProceedsFromIssuanceOfCommonStock
0
CY2022 femy Prepaid Insurance Financed With Promissory Note
PrepaidInsuranceFinancedWithPromissoryNote
141298
CY2022 femy Deferred Offering Costs Charged Against Certain Proceeds From Issuance Of Common Stock
DeferredOfferingCostsChargedAgainstCertainProceedsFromIssuanceOfCommonStock
95
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1643858
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3294
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
25093
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
21799
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
39976
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-94134505
CY2022 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
977
CY2021 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
0
CY2022Q4 femy Reserves For Uncollectible Accounts
ReservesForUncollectibleAccounts
2048
CY2021Q4 femy Reserves For Uncollectible Accounts
ReservesForUncollectibleAccounts
2026
CY2022 femy Inventory Disposals
InventoryDisposals
2847
CY2021 femy Inventory Disposals
InventoryDisposals
586
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2103
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
850
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
3294
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
244498
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
111531
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
100453
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
12795
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
91772
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
83944
CY2022Q4 us-gaap Inventory Net
InventoryNet
436723
CY2021Q4 us-gaap Inventory Net
InventoryNet
208270
CY2022Q4 femy Research Tax Credits
ResearchTaxCredits
891062
CY2021Q4 femy Research Tax Credits
ResearchTaxCredits
766571
CY2022Q4 femy Research Tax Credits Current
ResearchTaxCreditsCurrent
212134
CY2021Q4 femy Research Tax Credits Current
ResearchTaxCreditsCurrent
184638
CY2022Q4 femy Research Tax Credits Noncurrent
ResearchTaxCreditsNoncurrent
678928
CY2021Q4 femy Research Tax Credits Noncurrent
ResearchTaxCreditsNoncurrent
581933
CY2022Q4 femy Research Tax Credits
ResearchTaxCredits
891062
CY2021Q4 femy Research Tax Credits
ResearchTaxCredits
766571
CY2021Q4 femy Clinical Holdback Liability
ClinicalHoldbackLiability
168738
CY2022 femy Clinical Holdback Retained
ClinicalHoldbackRetained
21456
CY2022 femy Clinical Holdback Paid
ClinicalHoldbackPaid
48330
CY2022Q4 femy Clinical Holdback Liability
ClinicalHoldbackLiability
141864
CY2022Q4 femy Clinical Holdback Current
ClinicalHoldbackCurrent
45206
CY2022Q4 femy Clinical Holdback Noncurrent
ClinicalHoldbackNoncurrent
96658
CY2022 us-gaap Depreciation Expense On Reclassified Assets
DepreciationExpenseOnReclassifiedAssets
521151
CY2021 us-gaap Depreciation Expense On Reclassified Assets
DepreciationExpenseOnReclassifiedAssets
532552
CY2022 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
28234
CY2022 us-gaap Property Plant And Equipment Gross Period Increase Decrease
PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease
2285
CY2021 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
11401
CY2021 us-gaap Property Plant And Equipment Gross Period Increase Decrease
PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease
3098
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2022 femy Minimum Term To Record Operating Leases As Right To Use Assets And Operating Lease Liabilities
MinimumTermToRecordOperatingLeasesAsRightToUseAssetsAndOperatingLeaseLiabilities
P1Y
CY2022 femy Minimum Term To Record Finance Leases As Right To Use Assets And Finance Lease Liabilities
MinimumTermToRecordFinanceLeasesAsRightToUseAssetsAndFinanceLeaseLiabilities
P1Y
CY2022 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P3Y
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1668951
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1668951
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1665657
CY2022 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
232845
CY2022Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
95
CY2021Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
188544
CY2021Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
1591143
CY2022Q4 femy Deferred Offering Costs Capitalized
DeferredOfferingCostsCapitalized
232750
CY2021Q4 femy Deferred Offering Costs Capitalized
DeferredOfferingCostsCapitalized
0
CY2022Q4 femy Accrued Clinical Trial Cost
AccruedClinicalTrialCost
333440
CY2021Q4 femy Accrued Clinical Trial Cost
AccruedClinicalTrialCost
301730
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
85191
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
98272
CY2022Q4 femy Franchise Taxes
FranchiseTaxes
26886
CY2021Q4 femy Franchise Taxes
FranchiseTaxes
103020
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
11197
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
100765
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
456714
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
603787
CY2020Q4 femy Clinical Holdback Liability
ClinicalHoldbackLiability
164972
CY2021 femy Clinical Holdback Retained
ClinicalHoldbackRetained
15503
CY2021 femy Clinical Holdback Paid
ClinicalHoldbackPaid
11737
CY2021Q4 femy Clinical Holdback Liability
ClinicalHoldbackLiability
168738
CY2021Q4 femy Clinical Holdback Current
ClinicalHoldbackCurrent
18947
CY2021Q4 femy Clinical Holdback Noncurrent
ClinicalHoldbackNoncurrent
149791
CY2021 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
0
CY2022 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
0
CY2022Q4 femy Contract With Customer Unsatisfied Performance Obligation
ContractWithCustomerUnsatisfiedPerformanceObligation
0
CY2021Q4 femy Contract With Customer Unsatisfied Performance Obligation
ContractWithCustomerUnsatisfiedPerformanceObligation
0
CY2022 femy Percentage Of Restocking Fee
PercentageOfRestockingFee
0.30
CY2022 us-gaap Advertising Expense
AdvertisingExpense
41022
CY2021 us-gaap Advertising Expense
AdvertisingExpense
27000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0
CY2021 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
821515
CY2022 femy Number Of Extension Option For Operating Lease Term
NumberOfExtensionOptionForOperatingLeaseTerm
2
CY2022 femy Lessee Operating Lease Option To Extend Term
LesseeOperatingLeaseOptionToExtendTerm
P5Y
CY2022Q4 femy Current Market Rate
CurrentMarketRate
1
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
45659
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
307761
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
635668
CY2022Q4 femy Operating Lease Asset
OperatingLeaseAsset
307761
CY2021Q4 femy Operating Lease Asset
OperatingLeaseAsset
635668
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
357640
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
383616
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
28584
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
386224
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
386224
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
769840
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.10
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.10
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y1M6D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y1M6D
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
485598
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
487746
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
5730
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
3343
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
41198
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
17497
CY2022 us-gaap Lease Cost
LeaseCost
532526
CY2021 us-gaap Lease Cost
LeaseCost
508586
CY2022Q4 femy Operating And Finance Lease Liability Current
OperatingAndFinanceLeaseLiabilityCurrent
373833
CY2022Q4 femy Operating And Finance Lease Liability Noncurrent
OperatingAndFinanceLeaseLiabilityNoncurrent
28584
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0
CY2022Q4 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
150122
CY2021Q4 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
150122
CY2022Q4 us-gaap Finance Lease Right Of Use Asset Accumulated Amortization
FinanceLeaseRightOfUseAssetAccumulatedAmortization
138326
CY2021Q4 us-gaap Finance Lease Right Of Use Asset Accumulated Amortization
FinanceLeaseRightOfUseAssetAccumulatedAmortization
120043
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
11796
CY2021Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
30079
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
16193
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
23058
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
0
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
16193
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
16193
CY2021Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
39251
CY2022Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.10
CY2021Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.10
CY2022Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0Y8M12D
CY2021Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y7M6D
CY2022 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
18283
CY2021 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
18540
CY2022 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
2892
CY2021 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
5090
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
557500
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
47029
CY2022Q4 femy Operating Lease Liability To Be Paid
OperatingLeaseLiabilityToBePaid
604529
CY2022Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
16792
CY2022Q4 femy Finance Lease Liability To Be Paid
FinanceLeaseLiabilityToBePaid
16792
CY2022Q4 femy Lessee Operating Lease And Finance Lease Liability Payments Due
LesseeOperatingLeaseAndFinanceLeaseLiabilityPaymentsDue
621321
CY2022Q4 femy Lessee Operating Lease And Finance Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseAndFinanceLeaseLiabilityUndiscountedExcessAmount
218904
CY2022Q4 femy Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
402417
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
6300
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
4000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
6300
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
4000
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-2797001
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1913368
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
371982
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-98744
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2425019
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2012112
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2425019
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2012112
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6300
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.02
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.01
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.03
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.01
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.01
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.21
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.27
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
17869574
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
16873473
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
7625
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
13920
CY2022Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
90508
CY2021Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
82451
CY2022Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
41279
CY2021Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
0
CY2022Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
1487512
CY2021Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
0
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
3088254
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
3190604
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
46312
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
20207
CY2022Q4 femy Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
90224
CY2021Q4 femy Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
188789
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1189
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
8898
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
22722477
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
20378342
CY2022Q4 femy Deferred Tax Liabilities Uniform Capitalization
DeferredTaxLiabilitiesUniformCapitalization
10733
CY2021Q4 femy Deferred Tax Liabilities Uniform Capitalization
DeferredTaxLiabilitiesUniformCapitalization
10615
CY2022Q4 femy Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
71646
CY2021Q4 femy Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
138239
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
0
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
14409
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
82379
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
163263
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
22640098
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
20215079
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2425019
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2012112
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
82500657
CY2017Q1 femy Number Of Shares Authorized For All Classes Of Stock
NumberOfSharesAuthorizedForAllClassesOfStock
169000000
CY2017Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.001
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9
CY2022 us-gaap Common Stock Voting Rights
CommonStockVotingRights
one
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
233400
CY2022Q2 femy Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
11112
CY2022 us-gaap Dividends Common Stock
DividendsCommonStock
0
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11869704
CY2021Q2 femy Number Of Equity Incentive Plans
NumberOfEquityIncentivePlans
2
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
743627
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.6
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
44698
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.83
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
556
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
27
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
8378
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.43
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
689995
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.58
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
367670
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.33
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
9445
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.71
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
10558
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
27
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
106112
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.09
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
931550
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.97
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
367670
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3306
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
159062
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
931550
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y2M23D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
449441
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
3.32
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y6M29D
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P10Y
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
224939
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
193366
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1058218
CY2022 femy Share Based Compensation Expense To Be Recognized Upon Achieving Certain Performance Condition
ShareBasedCompensationExpenseToBeRecognizedUponAchievingCertainPerformanceCondition
463311
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
594907
CY2022 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y10M24D
CY2022 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
73947
CY2021 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
0
CY2021 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0
CY2022 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11394170
CY2022 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-11394170
CY2021 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-7537845
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7537845
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11815019
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11815019
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6712028
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6712028
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.96
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.96
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.12
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.12
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1081550
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
689995
CY2022 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
233460
CY2021 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
244572
CY2022 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1315010
CY2021 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
934567

Files In Submission

Name View Source Status
0001140361-23-014668-index-headers.html Edgar Link pending
0001140361-23-014668-index.html Edgar Link pending
0001140361-23-014668.txt Edgar Link pending
0001140361-23-014668-xbrl.zip Edgar Link pending
brhc10050340_10k.htm Edgar Link pending
brhc10050340_ex23-1.htm Edgar Link pending
brhc10050340_ex31-1.htm Edgar Link pending
brhc10050340_ex31-2.htm Edgar Link pending
brhc10050340_ex32-1.htm Edgar Link pending
brhc10050340_ex32-2.htm Edgar Link pending
femy-20221231.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image00001.jpg Edgar Link pending
image00003.jpg Edgar Link pending
image00004.jpg Edgar Link pending
image00005.jpg Edgar Link pending
image00007.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
femy-20221231_lab.xml Edgar Link unprocessable
femy-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
brhc10050340_10k_htm.xml Edgar Link completed
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
femy-20221231_cal.xml Edgar Link unprocessable
femy-20221231_def.xml Edgar Link unprocessable